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THE ROLE OF PROSTAGLANDIN E, CYCLIC AMP, AND CYCLIC GMP 
IN THE PROLIFERATION OF GUINEA-PIG EAR SKIN STIMULATED 
BY TOPICAL APPLICATION OF VITAMIN A ACID 
KAZUO Aso, M .D., ISRAEL RABINOWITZ, PH.D., AND EUGENE M. FARBER, M.D. 
Department of Dermatology, Stanford University School of Medicine, Stanford, California, U. S. A. 
Daily treatment of guinea-pig ear skin with topical 0.5 % retinoic acid in acetone produced 
erythematous scaly dermatitis. Histologic sections revealed bandlike thickening of the 
epidermis on days 2 to 4, psoriasiform acanthosis, papillomatosis and increased mitotic 
activity on days 5 to 6. Also seen were dilatation of the upper dermal blood vessels and a 
fibroblastic, histiocytic reaction in the dermis. Prostaglandin E, cyclic AMP, and cyclic GMP 
levels were increased in the treated skin and thymidine incorporation was enhanced. Cyclic 
AMP and GMP levels peaked on day 5 simultaneous with maximal epidermal hyperplasia, 
increased mitotic activity and dermal reaction. Tritiated thymidine uptake peaked on days 4 
and 5, and prostaglandin E levels continued to increase up to day 6. Cyclic AMP 
phosphodiesterase activity of treated skin on day 5 did not appear to be significantly different 
from control. 
The regulatory program which adjusts the 
growth rate of cells to variable environmental 
conditions has been called the "pleiotypic" re-
sponse [1]. There is ample evidence that this 
response involves cyclic nucleotides [2-5], and 
these nucleotides have been implicated in the 
control of epidermal proliferation [6]. The infl u-
ence of cyclic nucleotide concentration variations 
on cell proliferation in the skin, however, has not 
been clearly defined. The relationship between 
components of the modulatory system controlling 
cyclic nucleotide concentrations such as prosta-
glandins (PGs) and phosphodiesterase (PDE) is 
likewise not yet fully understood. 
In order to describe the interaction between 
these control elements of cyclic nucleotide levels in 
the skin and to gain further insight into the role of 
cyclic nucleotides in epidermal proliferation, we 
have used vitamin A acid (retinoic acid, RA)-
treated guinea-pig ear skin as an experimental 
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Ab breviations: 
cAMP: 3' ,5 '-cyclic adenosine monophosphate 
cGMP: 3' ,5 ' -cyclic guanosine monophosphate 
PCA: perchloric acid 
PDE: phosphodiesterase 
PGs: prostaglandins 
RA: retinoic acid 
model. This model mimics several of the features 
of psoriatic proliferation [7]. 
MATERIALS AND METHODS 
Thirty male albino guinea pigs , 3 to 5 months old, from 
several suppliers were used , although animals from the 
same supplier were always used for matched control vs 
treated experiments . Retinoic acid (0 .5%) (Sigma crys-
talline type XX) was made up in reagent grade acetone 
and was applied with 5 cotton swab touches to the upper 
side of the right ear daily for 6 days . An equal number of 
swab applications of acetone was applied to the left 
control ear. 
On appropriate days animals were sacrificed, exsan-
guinated, and the outer two-thirds of the treated and 
control ears were cut off. Time between sacrifice and 
tissue homogenization was usually under 3 min . The 
remaining RA on the ears was removed with acetone , and 
each ear was cut into 4 pieces for assays of PG E and 
cAMP, measurement of thymidine uptake, and histologic 
study. Cyclic GMP was assayed in whole ear skin from 6 
animals, both ears of which had been treated for 2 to 6 
days. This procedure was necessary in order to obtain 
enough tissue for the cGMP radioimmunoassay. For 
cAMP and cGMP assays, tissue was immediately placed 
in ice-cold 6% trichloroacetic acid (TCA), and for PGE 
assay, tissue was initially extracted with chloroform: me-
thanol, 2: 1. For thymidine uptake studies, tissue was 
placed in cold Bullough's buffer solution [8]. For 
cAMP-PDE assay whole ear skin of 4 treated and 4 
control ears was immediately homogenized in ice-cold 40 
mM Tris-HCI buffer, pH 8.0, and centrifuged at 10,000 x 
g for 20 min at 4 DC. The supernatant fraction was used 
for assay. 
[3H]cAMP (spec act 37.7 Ci/mole) and [3H]thymidine 
(spec act 40 Ci/mole) were purchased from New England 
Nuclear. 5'-Nucleotidase, as lyophilized crotalus ada-
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menteus venom, was obtained from Sigrn-a Chemical Co. 
The PGE and cGMP radioimmunoassay kits were pur-
chased from Collaborative Research Inc. All other chemi-
cals used were reagent grade. 
Assay protocols. Cyclic AMP: Tissue was homogenized 
in 2 ml of ice-cold 6% TCA using a glass homogenizer 
and centrifuged at 10,000 x g for 20 min at 4°C. The 
supernatant was washed with water-saturated ether 3 
times, lyophilized, and redissolved in 0.05 M acetate 
buffer, pH 4.0. The nucleotide determination was done 
using the Gilman method [9] with bovine kidney cAMP 
binding protein prepared as described by Cheung and 
Patrick [10]. Cyclic GMP: The ether-extracted superna-
tant, as above, was passed through Dowex 1, X-8 
(chloride form, 200 mesh) which was prewashed with 3 M 
sodium formate in 6 M formic acid, several bed volumes of 
88% formic acid , and distilled water until the effluent pH 
was neutral. Elution of bound nucleotides was performed 
following the technique of Murad et al [11]. The eluate 
was lyophilized and redissolved in 0.05 M acetate buffer, 
pH 6.2, and assayed via radioimmunoassay. PGE: Assay 
was carried out as previously described [12] except that 
the homogenized extract was treated with chloroform: 
methanol, 2:1, Thymidine uptake: From 50 to 100 mg 
wet weight tissue slices were incubated for 2 hr in 4 ml of 
Bullough's solution containing 1 /-LCi/ml of [3H]thymi-
dine under 95% O2 , 5% CO 2 at 37°C . The reaction was 
terminated by placing the tissue in 2 ml of 1 N perchloric 
acid (PCA) and the tissue was homogenized in the cold. 
The precipitate after centrifugation was washed 3 times 
with 0.3 N PCA and heated at 80°C for 20 min in 3 ml of 
0.5 N PCA. After neutralizaion with 5 N KOH, radioac-
tivity of the supernatant was analyzed via liquid scintil-
lation using 10 ml of Bray's solution [13] per sample. 
DNA concentration was measured by the method of 
Burton [14]. PDE: Five hundred milligrams of tissue was 
homogenized and reaction tubes containing, respectively, 
0, 10- 6 , 10- 7 M added cAMP were analyzed as described 
by Cheung et al [15]. After incubation for 20 min at 30°C, 
the reaction was terminated by adding TCA to a final 
concentration of 6%, and centrifuging at 10,000 x g, 4°C, 
20 min. The supernatant was assayed for inorganic 
phosphate following the method of Wuthier [16]. Protein 
was determined by the method of Lowry et al [17] using 
aliquots from the same supernatant. Hyperplasia of 
epidermis was measured by projecting a constant area of 
tissue section under constant magnification onto paper of 
uniform thickness . The epidermal area was outlined, cut, 
and weighed. 
RESULTS 
The majority of the data are summarized in the 
Figure. Erythema of the treated ears was first 
noted after 2 days of treatment and became 
prominent after 3 days. An erythematous, scaly 
dermatitis was apparent on days 5 and 6. Histo-
logic sections revealed bandlike thickening of the 
epidermis on days 2 to 4 and psoriasiform acantho-
sis as well as papillomatosis on days 5 and 6 
(phases II and III of Braun-Falco and Christophers 
[7]). As had been noted by Jarrett and Spearman 
[18] on mouse back skin, we found a parakeratotic 
horny layer overlaying a prominent granular layer 
in vitamin A-acid-treated guinea-pig ear skin. 
Mitotic figures were counted per unit of epidermal 
surface area of treated and; control skin for each 
day. Mitotic figures increased starting between 
days 3 and 4 and reached a peak on day 5. Tissue 
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sections showed a slight hyperplasia of the epider-
mis on the opposite side of the treated ears as well 
as on the acetone-treated sides of the control ears 
on day 5. 
Thymidine uptake reached a peak at days 4 and 
5. At day 6, the uptake decreased, There was no 
significant increase of thymidine incorporation in 
tissue from the control ears. After day 2, cAMP 
concentrations were uniformly higher in the 
treated ears than in the control ears and there was 
a 5-fold rise in cAMP concentration on day 5 as 
compared to nontreated skin. The smaller increase 
in cAMP on day 5 in the control skin was probably 
attributable to cumulative nonspecific acetone 
damage to tissue (Fig.). The concentration of 
cGMP for treated ears on day 5 was significantly 
higher than the control values. 
The increase in PGE levels noted at day 2 for the 
treated skin was significantly higher than the 
levels at either day 3 (p < .005) or day 1 (p < 
.001). The increased levels of PG E remained higher 
than control values for all days of treatment and 
continued to increase up to day 6 as shown in the 
Figure. 
PDE activity on day 5 in the presence of added 
cAMP substrate increased as the concentration of 
substrate increased from 0 to 10- 6 M. The activity 
as expressed by released f.Lg P)mg protein was 14.4 
± 1.6 without added cAMP, 15.7 ± 1.1 at 10- 7 M, 
and 16.7 ± 1.1 at 10- 6 M concentration of added 
cAMP in the control skin. The corresponding 
values for treated skin were 10.6 ± 1.3,17.6 ± 1.1, 
and 18.7 ± 2.1. The activity of PDE in the treated 
ears was not statistically different than those of 
control ears, the mean p value for the three 
concentrations being ~ .16. 
DISCUSSION 
Topical RA stimulates proliferation of guinea-
pig ear skin in vivo with dilatation of dermal blood 
vessels with erythema and increased cell division 
accompanied by epidermal hyperplasia, as well as 
a fibroblastic and histiocytic reaction in the der-
mis. The most apparent feature of the latter stage 
of this stirn ulation is a scaly, erythematous, psoria-
siform dermatitis. These observations are almost 
identical to those of Braun-Falco and Christophers 
[7], although they did not report decreased DNA 
synthesis in the treated skin after day 5 of daily 
treatment as observed here. The first stage of this 
response comprises a useful model of epidermal 
proliferation and this early stage of stimulation has 
been well studied and confirmed [19,20]. 
The level of cAMP rises with proliferation to a 
peak concentration on day 5. This peak concentra-
tion was seen simultaneously with maximal epider-
mal hyperplasia, with increased mitotic activity 
and with dermal reactions. The stimulated synthe-
sis of cAMP, therefore, may represent a coor-
dinated response of all cell types in the proliferat-
ing skin. A similar pattern of increased cAMP 
levels during cell growth of cultured fibroblasts has 
been described, in which cAMP reached its peak 
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FIG. l. Variation of concentrations of cAMP, cGMP, and PGE in relation to tritiated thymidine uptake and 
epidermal hyperplasia in retinoic acid-treated guinea-pig ear skins. Each point represents average levels (closed circle 
for treated; open circle for control skin) and bars indicate estimated standard deviations . For PGE, 2 control and 2 
treated animals were sacrificed per day, and each animal assay was performed in duplicate . For cAMP and thymidine 
uptake as well as hyperplasia measurement, 4 control and 4 treated animals were sacrificed per day and each animal 
assay was performed in duplicate. For cGMP, as explained in the text, both ears of 1 treated animal per day were 
assayed in duplicate and on day 5, an additional 3 animals were tested for cGMP levels. One ear of each animal was 
treated, and the other ear was acetone-treated control. 
when the cells exhibited density-dependent inhibi-
tion of growth [5]. 
Although the increased levels of cyclic nucleo-
tides were measured in whole skin, the epidermis 
must be held responsible for approximately 75 % of 
this total, since the dermis normally synthesizes 
one quarter of the amount of cAMP which is 
synthesized in the epidermis (unpublished data). 
Furthermore, the histologic appearance of the 
dermis remains relatively constant throughout the 
treat ment, while the epidermis undergoes striking 
changes . The increased cAMP concentration dur-
ing the observed proliferation suggests that cAMP 
is more closely involved with differentiation than 
with cell division, supported by the fact that 
thymidine incorporation peaks before the increase 
in cAMP accumulation . Additional evidence sup-
orting this view comes from the observations of 
Grim and Marks [21] and of Krieg et al [22], that 
~ here is no correlation of peak DNA synthesis with 
:)eak cAMP synthesis , and that histidine incorpo-
;,ation occurs simultaneously or immediately after 
. he peak of cAMP accumulation in phorbol ester-
. timulated mouse epidermis. This latter finding 
:orroborates the observation of Delescluse et al 
\23] that dibutyryl cAMP enhances incorporation 
i)f histidine in keratinocytes in culture , suggesting 
·.i possible role of cAMP in epidermal keratiniza-
jon. The specific role of cAMP in the differentia-
tion of melanocytes [24,25] and neuroblastoma 
cells in culture [26,27] likewise supports this view 
of cAMP function in proliferating skin. 
Recent studies tend to indicate that cG MP plays 
a critical role in cell division [3,4]. It has been 
demonstrated that increases in cGMP concentra-
tion in fibroblasts were observed only when cul-
tures which were arrested in the Go phase were 
stimulated to grow, or when synchronized growing 
cells passed through the G1 phase [3] . The in-
creased level of cGMP on day 5 in proliferating 
skin might reflect a role of this cyclic nucleotide in 
increased cell division of the basal cells. 
The catecholomines, notably epinephrine, are 
known to stimulate epidermal cAMP synthesis 
[28 ,29], although the concentrations necessary do 
not appear to be physiologic. The experimental 
design utilized in this study argues against sys-
temic stimulation of cAMP accumulation in the 
skin , as stimulation of one ear did not affect 
synthesis in the control ear skin other than that 
due to the nonspecific acetone effect. The release of 
PGE is more likely to represent the initial local 
response to trauma which in turn participates in 
the modulation of cAMP accumulation. This is 
supported by previous work showing that physio-
logic concentrations of PGE 1 stimulated cAMP 
synthesis in the epidermis [12], and the demon-
stration in this work that the increase in PGE 
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concentration occurs prior to the increase in 
cAMP. The initial PGE increase at day 2, which is 
followed by a relative decrease at day 3 indicates 
that PGE may also be involved in the early 
erythematous response of the dermal blood vessels 
[30]. 
Although we have observed that the activity of 
cAMP-PDE in the treated skin at day 5 is not 
significantly greater than control, the possibility 
remains that the activity of the enzyme is in-
creased at an earlier time, as has been found for 
growing fibroblasts in culture [5]. 
The increase in cAMP concentration concomi-
tant with the proliferation of vitamin A-stimulated 
ear skin may at least in part be due to increased 
PGE synthesis. It is also possible that the in-
creased concentration of cGMP (noted here on day 
5) may inhibit cAMP-PDE activity as has been 
demonstrated in other tissue types [31], thus 
contributing to increased cAMP concentration. 
The data presented show that variations in the 
concentration of cAMP play an important regula-
tory role in the control of epidermal proliferation or 
differentiation. The data also support the conclu-
sion that PGE synthesis and release stimulates 
cAMP accumulation, but it remains to be demon-
strated what the roles of cGMP concentration and 
PDE activity are in this regulatory activity. 
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